Inflammatory diseases involve numerous disorders and medical conditions defined by an
insufficient level of self-tolerance. These diseases evolve over the course of a multi-step …

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease. The inconsistent
prevalence of SLE between monozygotic twins suggests that environmental factors affect the …

Background Cancer onset and progression are driven by genetic and epigenetic alterations
leading to oncogene activation and the silencing of tumor suppressor genes. Among …

Objective Researchers are actively investigating new diagnostic and prognostic biomarkers
that offer improved sensitivity and specificity for systemic lupus erythematosus (SLE). One …

Abstract Background and Objectives Systemic lupus erythematosus (SLE) is distinguished
by dysregulated immune system activity, resulting in a spectrum of clinical manifestations …

Introduction DNA hypomethylation in patients with systemic lupus erythematosus (SLE) has
been recently documented in the literature. Low levels of DNA methylation have been …

Increasing evidence reveals that epigenetic biomarkers, mainly markers of DNA methylation
or noncoding RNA molecules, can become valuable tools as minimally invasive diagnostic …

Background. Gastric cancer (GC) is a significant global health concern, ranking as the fifth
most common malignant tumor and the fourth leading cause of cancer-related deaths …